// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Modelling and predicting the long-term clinical outcome of autologous chondrocyte implantation

J.H. Kuiper - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The RNA binding protein HuR is critical for effective differentiation of bone marrow derived stem cells

B.T. McDermott - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bromodomain inhibitors are potent epigenetic regulators of catabolic gene expression in human osteoarthritic chondrocytes

M.C. de Andrs - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interleukin

Exploring the social life of mesenchymal stromal cells by label-free tracking of individual and collective cell behaviour

A.L. Barnes - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Genotype at the MGP OA risk locus correlates with an expression quantitative trait locus operating on MGP in cartilage and with dna methylation at a cluster of regulatory CpGs within ARHGDIB

C. Shepherd - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Modification of the SUPT3H/RUNX2-dmr using CRISPR/Cas9 demonstrates functional regulation of RUNX2 expression

S.J. Rice - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Paragangliomas 3

N/A

The long non-coding RNA CASC20 is a susceptibility locus for heterotopic ossification: results of a genome-wide association study

K. Hatzikotoulas - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Modelling genetic mechanisms of osteoarthritis using human induced pluripotent stem cells

E. Cibrian Uhalte - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Polymorphic variants in ALDH1A2 determine the expression level of ALDH1A2 and CYP19A1 in the cartilage of patients undergoing trapeziectomy for severe thumb osteoarthritis

L. Zhu - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

microRNA-455 is regulated in a circadian manner and targets a number of components of the circadian rhythm

T.E. Swingler - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Chondrosarcoma

Dexamethasone

Genome-wide DNA methylation study of hand osteoarthritis

M.S. Yau - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Rheumatoid arthritis

N/A

The effect of U3 snoRNA knockdown on the chondrocyte proteome

A. Smagul - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

amphotericin b cholesteryl sulfate complex Intravenous

snoRNA signatures in cartilage ageing and osteoarthritis

M.J. Peffers - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Interleukin

The role of microRNA 144 in osteoarthritis

L. Le - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Osteoarthritis

N/A

A role for small nucleolar RNA host genes in cartilage ageing and osteoarthritis

M.J. Peffers - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The role of microRNAs in tendon dysfunction

D. Bardell - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

anti-thymocyte equine

Characterisation of mice lacking miR-140 and its host gene Wwp2

Y. Hao - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The differential expression and functional role of long non coding RNAs in inflamed synovial tissue from patients with hip osteoarthritis

M.J. Pearson - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The role of microRNA 3085 in chondrocytes

L. Le - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Defining the role and mechanisms of microRNAs in cartilage ageing and disease

P. Balaskas - Osteoarthritis Research Society International (OARSI) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved